We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$96.1B
AUM Growth
-$20.7B
Cap. Flow
-$1.83B
Cap. Flow %
-1.91%
Top 10 Hldgs %
18.42%
Holding
4,634
New
1,015
Increased
1,222
Reduced
1,970
Closed
108

Top Sells

Rank Stock Value
1
FXI icon
iShares China Large-Cap ETF
FXI
+$256M
2
C icon
Citigroup
C
+$159M
3
PCG icon
PG&E
PCG
+$138M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$132M
5
UBS icon
UBS Group
UBS
+$113M

Sector Composition

Rank Sector Weight
1 Technology 21.62%
2 Healthcare 16.32%
3 Financials 13.63%
4 Consumer Discretionary 9.13%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRU icon
4126
Spruce Power Holding Corp
SPRU
$44.5M
-9,291
Closed -$149K
SPRY icon
4127
ARS Pharmaceuticals
SPRY
$534M
$0 ﹤0.01%
+11
New +$38
SQQQ icon
4128
ProShares UltraPro Short QQQ
SQQQ
$1.71B
-707
Closed -$595K
SSKN
4129
DELISTED
Strata Skin Sciences
SSKN
$0 ﹤0.01%
+1
New +$12
STIM icon
4130
Neuronetics
STIM
$159M
$0 ﹤0.01%
+14
New +$41
STKH
4131
Steakholder Foods
STKH
$1.55M
0
STKS icon
4132
The ONE Group
STKS
$55.6M
$0 ﹤0.01%
+22
New +$201
STRO icon
4133
Sutro Biopharma
STRO
$426M
$0 ﹤0.01%
5
-2,712
-100% -$151K
STRS icon
4134
Stratus Properties
STRS
$159M
$0 ﹤0.01%
+8
New +$314
STTK icon
4135
Shattuck Labs
STTK
$727M
$0 ﹤0.01%
14
-11,237
-100% -$40.7K
STXS icon
4136
Stereotaxis
STXS
$138M
$0 ﹤0.01%
+26
New +$62
SURG icon
4137
SurgePays
SURG
$5.28M
$0 ﹤0.01%
+1
New +$4
SVRA icon
4138
Savara
SVRA
$1.13B
$0 ﹤0.01%
+2
New +$3
SWKH
4139
DELISTED
SWK Holdings
SWKH
$0 ﹤0.01%
+9
New +$134
SYRE icon
4140
Spyre Therapeutics
SYRE
$8.94B
$0 ﹤0.01%
+1
New +$35
TARS icon
4141
Tarsus Pharmaceuticals
TARS
$2.65B
$0 ﹤0.01%
+13
New +$195
TCBX icon
4142
Third Coast Bancshares
TCBX
$729M
$0 ﹤0.01%
+10
New +$232
TCI icon
4143
Transcontinental Realty Investors
TCI
$360M
$0 ﹤0.01%
+6
New +$250
TCRT icon
4144
Alaunos Therapeutics
TCRT
$4.71M
-2,022
Closed -$193K
TENX icon
4145
Tenax Therapeutics
TENX
$500M
0
TERN
4146
DELISTED
Terns Pharmaceuticals
TERN
$0 ﹤0.01%
+7
New +$14
TIL icon
4147
Instil Bio
TIL
$49.2M
$0 ﹤0.01%
+3
New +$425
TISI icon
4148
Team
TISI
$78.4M
$0 ﹤0.01%
+1
New +$14
TKC icon
4149
Turkcell
TKC
$4.74B
$0 ﹤0.01%
+1
New +$3
TKNO icon
4150
Alpha Teknova
TKNO
$302M
$0 ﹤0.01%
+7
New +$74

Similar funds

Credit Suisse's Q2 2022 Portfolio in Review

As of Q2 2022, Credit Suisse held 4,634 positions worth $96.1B, down 18% from $117B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Credit Suisse's Q2 2022 filing shows 1,015 new, 1,222 increased, 1,970 reduced and 108 closed positions. Its largest new stake was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M. The largest sale was iShares China Large-Cap ETF, an estimated $256M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q2 2022 buy was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $278M increase.
  • Credit Suisse's biggest Q2 2022 reduction was iShares China Large-Cap ETF, cutting an estimated $256M.
  • Credit Suisse fully exited Cerner Corp in Q2 2022, selling an estimated $46M.
  • Credit Suisse's ten largest holdings make up 18% of its $96.1B portfolio in Q2 2022.
  • Credit Suisse opened 1,015 new positions and closed 108 in Q2 2022.
  • Credit Suisse's portfolio value fell 18% quarter-over-quarter to $96.1B.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.